7-[3,5-bis(trifluoromethyl)phenyl]-4-({2-(dimethylamino)-5-[4-fluoro-2-methoxy-5-(1-methylethyl)phenyl]pyrimidin-4-yl}methyl)-6-oxa-4-azaspiro[2.4]heptan-5-one | 1616347-49-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 7-[3,5-bis(trifluoromethyl)phenyl]-4-({2-(dimethylamino)-5-[4-fluoro-2-methoxy-5-(1-methylethyl)phenyl]pyrimidin-4-yl}methyl)-6-oxa-4-azaspiro[2.4]heptan-5-one
• 英文别名: 7-[3,5-Bis(trifluoromethyl)phenyl]-4-({2-(dimethylamino)-5-[4-fluoro-2-methoxy-5-(1-methylethyl)phenyl] pyrimidin-4-yl} methyl)-6-oxa-4-azaspiro[2.4]heptan-5-one；7-[3,5-bis(trifluoromethyl)phenyl]-4-[[2-(dimethylamino)-5-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)pyrimidin-4-yl]methyl]-6-oxa-4-azaspiro[2.4]heptan-5-one
• CAS: 1616347-49-9
• 化学式: C₃₀H₂₉F₇N₄O₃
• 分子量: 626.574
• InChiKey: GVRLSMLSQQDGKB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.7
• 重原子数：
  44
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  67.8
• 氢给体数：
  0
• 氢受体数：
  13

文献信息

• [EN] SPIROCYCLIC CETP INHIBITORS<br/>[FR] INHIBITEURS DE LA CETP SPIROCYCLIQUES
  申请人：MERCK SHARP & DOHME

  公开号：WO2014099836A1

  公开（公告）日：2014-06-26

  Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and may be useful for raising HDL-cholesterol and reducing LDL-cholesterol in human patients and for treating or preventing atherosclerosis. The chemical compounds that are disclosed cholesterol ester transfer protein (CETP) and are expected to have utility in raising HDL-C, lowering LDL-C, and in the treatment and prevention of atherosclerosis.

  具有Formula (I)结构的化合物，包括这些化合物的药用盐，是CETP抑制剂，可能对提高人体患者的HDL胆固醇和降低LDL胆固醇，以及治疗或预防动脉粥样硬化有用。这些化学化合物揭示了胆固醇酯转移蛋白（CETP），预计在提高HDL-C、降低LDL-C以及治疗和预防动脉粥样硬化方面具有用途。
• SPIROCYCLIC CETP INHIBITORS
  申请人：MERCK SHARP & DOHME CORP.

  公开号：US20150342931A1

  公开（公告）日：2015-12-03

  Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and may be useful for raising HDL-cholesterol and reducing LDL-cholesterol in human patients and for treating or preventing atherosclerosis. The chemical compounds that are disclosed cholesterol ester transfer protein (CETP) and are expected to have utility in raising HDL-C, lowering LDL-C, and in the treatment and prevention of atherosclerosis.

  具有公式(I)结构的化合物，包括该化合物的药学上可接受的盐，是CETP抑制剂，可以用于提高人体患者的HDL-胆固醇，降低LDL-胆固醇，并用于治疗或预防动脉硬化。这些化学化合物是胆固醇酯转移蛋白（CETP）的抑制剂，预计在提高HDL-C，降低LDL-C以及治疗和预防动脉硬化方面具有用途。
• US9717714B2
  申请人：——

  公开号：US9717714B2

  公开（公告）日：2017-08-01